SCHEMBL980682

SCHEMBL980682

CCn1ncc(OC)cc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE1A P54750 3/20 0.43
PDE1B Q01064 3/20 0.43
PDE1C Q14123 3/20 0.43
NPBWR1 P48145 8/20 0.38
MCHR1 Q99705 4/20 0.36
CYP3A4 P08684 1/20 0.35
KCNH2 Q12809 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
HTR2A P28223 2/20 0.35
HTR2B P41595 2/20 0.35
HTR2C P28335 1/20 0.35
HTR1A P08908 1/20 0.34
ADRA2A P08913 1/20 0.34
DRD2 P14416 1/20 0.34
ADRA2C P18825 1/20 0.34
DRD4 P21917 1/20 0.34
HRH2 P25021 1/20 0.34
HTR1B P28222 1/20 0.34
HTR7 P34969 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL980667 0.81 CYP1A2 (0.40) NPBWR1CYP3A4GAAKMT2AHTR2A
SCHEMBL1550906 0.78 NPBWR1 (0.59) PDE1APDE1BPDE1CNPBWR1MCHR1
SCHEMBL979263 0.75 HTR3A (0.38) KMT2A
SCHEMBL24574648 0.75 ALDH1A1 (0.38) PDE1APDE1BPDE1CCYP3A4GAA
SCHEMBL978625 0.73 KMT2A (0.44) PDE1APDE1BPDE1CGAAKMT2A
SCHEMBL24575300 0.73 GAA (0.37) PDE1APDE1BPDE1CGAAKMT2A
SCHEMBL22579477 0.73 KDM4E (0.45) GAAKMT2A
SCHEMBL24574764 0.70 CNR2 (0.44) GAAKMT2ADRD2DRD4
SCHEMBL4767149 0.69 AURKA (0.50) PDE1APDE1BPDE1CNPBWR1HTR2A
SCHEMBL13763660 0.69 PDE1A (0.54) PDE1APDE1BPDE1CNPBWR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2456765-B1 IMIDAZOLE DERIVATIVES AS MGLUR5 ANTAGONISTS HOFFMANN LA ROCHE (CH) 2013-05-01 EP disclosed
US-8334287-B2 Imidazoles HOFFMANN-LA ROCHE INC. (US) 2012-12-18 US disclosed
EP-2456765-A1 IMIDAZOLE DERIVATIVES AS MGLUR5 ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2012-05-30 EP disclosed
WO-2011006910-A1 IMIDAZOLE DERIVATIVES AS MGLUR5 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-01-20 WO disclosed
US-20110015202-A1 IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2011-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015202-A1 IMIDAZOLES GRM5, GRM1, GRIK5 PDE1A 1233/4885PDE1B 1043/4885PDE1C 1444/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.